Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a) |
Name |
Said Darwazah |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Executive Chairman |
||||
b) |
Initial notification /Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Hikma Pharmaceuticals PLC |
||||
b) |
LEI |
549300BNS685UXH4JI75 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
||||
b) |
Nature of the transaction
|
Market purchase of 20,000 Ordinary Shares by Capital Investment & Brokerage / Jordan Ltd. Co for and on behalf of Said Darwazah. |
||||
c) |
Price(s) and volume(s) |
Price(s): £15.9166 Volume(s): 20,000 |
||||
d) |
Aggregated information - Volume - Price |
£318,332.00 |
||||
e) |
Date of the transaction |
13 March 2019 |
||||
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
13 March 2019